External validation of a Dutch predictive nomogram for complete response to T-VEC in an independent American patient cohort.

9563Background: Talimogene Laherparepvec (T-VEC) is a genetically modified herpes simplex type 1 virus and known as an effective oncolytic immunotherapy for injectable cutaneous, subcutaneous, and ...